Moderna COVID-19 antibody seems safe, gives indications of working in more seasoned grown-ups: Study Kumar Jeetendra | September 30, 2020 Results from an early safety study of Moderna Inc’s coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those found in younger adults, with side effects about on par with high-dose flu shots, researchers said on Tuesday. The study, published in the New England Journal of Medicine, offers …
Russia finishes clinical preliminaries of second potential COVID-19 immunization Kumar Jeetendra | September 30, 2020 Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, the RIA news agency mentioned Russian customer safety watchdog Rospotrebnadzor as saying on Wednesday The institute completed early-stage human trials, known as Phase II, earlier this month.
Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay Kumar Jeetendra | September 30, 2020 Mechelen, Belgium, 30 September 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that it has received a EUR 1.2 million grant from VLAIO, the Flanders organization for Innovation & Entrepreneurship, for the development of the highly innovative GeneFusion Assay on its easy, rapid molecular …
PC model disentangles puzzle behind serious aggravation in individuals with COVID-19 Kumar Jeetendra | September 29, 2020 A study from the University of Pittsburgh School of Medicine and Cedars-Sinai addresses a mystery first raised in March: Why do some people with COVID-19 develop severe inflammation? The research shows how the molecular arrangement and arrangement of the SARS-CoV-2 spike protein–part of the virus that causes COVID-19–could be behind the inflammatory syndrome cropping up …
Why the Covid death rate actually escapes researchers Kumar Jeetendra | September 29, 2020 Global deaths from COVID-19 have reached 1 million, but experts are still struggling to figure out a key metric in the pandemic: the fatality rate – the percentage of people infected with the pathogen who die. A true mortality rate could compare deaths against the entire number of ailments, a denominator that remains unknown because …
BAT study dissects the toxicological effect of nicotine pocket items Kumar Jeetendra | September 28, 2020 New research by BAT suggests that contemporary oral goods (MOPs) revealed lower toxicity reactions in certain assays than traditional cigarettes. Scientists analyzed the toxicological impact of one of BAT’s nicotine pouch products, previously called Lyft and now called Velo, in an in vitro laboratory-based test. Velo was found to be less biologically active than cigarette …
Scientists study misleading impact in nausea therapy at the molecular level Kumar Jeetendra | September 28, 2020 The molecular bases of the placebo effect are poorly understood. A team headed by Ludwig-Maximilians-Universitaet (LMU) in Munich researcher Karin Meissner has now studied the phenomenon in the context of nausea, and identified specific proteins that correlate with its positive impact. The placebo effect seems to work wonders. In certain cases, administration of a’drug’ to …
Cat que infection: Another virus from China can possibly trigger general health emergency in India:ICMR Kumar Jeetendra | September 28, 2020 At a time when India is still grappling with the novel coronavirus pandemic that started in China’s Wuhan, scientists have warned of another virus from China that has the potential to spread diseases in India. Researchers at the Indian Council of Medical Research (ICMR) have discovered that the’cat que virus’ (CQV), that has infected many …
FDA endorsed drug ‘Teicoplanin’ discovered more powerful in treating COVID – 19 infection: IIT Delhi research Kumar Jeetendra | September 28, 2020 Clinically approved drug”Teicoplanin” is a potential therapeutic alternative against COVID-19 and may be ten times more effective than many drugs being currently used, a study by Indian Institute of Technology (IIT), Delhi has found. The research from the institute’s Kusuma School of Biological Science screened an assemblage of 23 approved drugs, which have shown leads …
Novel neuroimaging investigation on dissociative side effects uncovers wounds of youth Trauma Kumar Jeetendra | September 27, 2020 Trauma can cause dissociative side effect in individuals -, for example, encountering amnesia, an out-of-body understanding, feeling genuinely numb – which may help individuals adapt. Experiencing these symptoms intensely or for a long time, however, can negatively impact an individual’s ability to function. A group drove by examiners at McLean Hospital has now discovered that …
Translational exploration preparing program causes understudies to more readily comprehend patients’ issues Kumar Jeetendra | September 27, 2020 Translational research aims to speed research breakthroughs into the practice. And yet, training for basic scientists and clinicians too often remains siloed, resulting in divergent cultures and a lack of chance for cross-disciplinary collaboration. The South Carolina Clinical & Translational Research (SCTR) Institute’s TL1 application, a translational research training program for doctoral students in the …
Yale assigns three free research facilities to perform SalivaDirect COVID-19 test Kumar Jeetendra | September 26, 2020 Laboratory evaluations of surgical and N95 masks by researchers at the University of California, Davis, show that they do cut down the amount of aerosolized particles generated during breathing, coughing and talking. Tests of homemade fabric face coverings, however, show that the fabric itself releases a large amount of fibers to the air, underscoring the …
